
Audrea June Buckley Coniglio
Examiner (ID: 116, Phone: (571)270-1336 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617, 1611 |
| Total Applications | 1005 |
| Issued Applications | 507 |
| Pending Applications | 122 |
| Abandoned Applications | 422 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16310686
[patent_doc_number] => 20200289424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/647927
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647927 | PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS | Sep 30, 2018 | Pending |
Array
(
[id] => 16389492
[patent_doc_number] => 20200330433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST
[patent_app_type] => utility
[patent_app_number] => 16/754307
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754307
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754307 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITION OF APREMILAST | Sep 30, 2018 | Abandoned |
Array
(
[id] => 16310686
[patent_doc_number] => 20200289424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/647927
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647927 | PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS | Sep 30, 2018 | Pending |
Array
(
[id] => 16310686
[patent_doc_number] => 20200289424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/647927
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16647927
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/647927 | PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS | Sep 30, 2018 | Pending |
Array
(
[id] => 18962981
[patent_doc_number] => 11896720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Orally available articles containing at least one stabilized supplement therein
[patent_app_type] => utility
[patent_app_number] => 16/141070
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5677
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141070 | Orally available articles containing at least one stabilized supplement therein | Sep 24, 2018 | Issued |
Array
(
[id] => 15020557
[patent_doc_number] => 20190321283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOSITION AND METHOD FOR PREPARING A CUSTOMIZED PERSONAL CARE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 16/135587
[patent_app_country] => US
[patent_app_date] => 2018-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16135587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/135587 | COMPOSITION AND METHOD FOR PREPARING A CUSTOMIZED PERSONAL CARE PRODUCT | Sep 18, 2018 | Abandoned |
Array
(
[id] => 15338697
[patent_doc_number] => 10525002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Compound, composition, and method for protecting skin from high energy visible light
[patent_app_type] => utility
[patent_app_number] => 16/131027
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11988
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131027 | Compound, composition, and method for protecting skin from high energy visible light | Sep 13, 2018 | Issued |
Array
(
[id] => 14069279
[patent_doc_number] => 20190083527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHOD OF ADMINISTRATION AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/132357
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16132357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/132357 | METHOD OF ADMINISTRATION AND TREATMENT | Sep 13, 2018 | Abandoned |
Array
(
[id] => 16443585
[patent_doc_number] => 10835488
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Stable orally disintegrating pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/130494
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16111
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130494 | Stable orally disintegrating pharmaceutical compositions | Sep 12, 2018 | Issued |
Array
(
[id] => 16742019
[patent_doc_number] => 10966988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Method for smoking cessation
[patent_app_type] => utility
[patent_app_number] => 16/486762
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1337
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486762 | Method for smoking cessation | Sep 10, 2018 | Issued |
Array
(
[id] => 17741378
[patent_doc_number] => 11389421
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Transdermal therapeutic system for the transdermal administration of rivastigmine
[patent_app_type] => utility
[patent_app_number] => 16/641747
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 26262
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641747
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641747 | Transdermal therapeutic system for the transdermal administration of rivastigmine | Sep 3, 2018 | Issued |
Array
(
[id] => 16105405
[patent_doc_number] => 10695287
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => AMPK agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same
[patent_app_type] => utility
[patent_app_number] => 16/119024
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 2920
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119024
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119024 | AMPK agonist topical medication for the treatment of certain specific medical conditions, methods of use thereof and wound dressing employing the same | Aug 30, 2018 | Issued |
Array
(
[id] => 16153697
[patent_doc_number] => 20200215081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => SOLID PREPARATION COMPRISING DUTASTERIDE AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 16/642507
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642507 | Solid preparation comprising dutasteride and method for preparing same | Aug 29, 2018 | Issued |
Array
(
[id] => 16420394
[patent_doc_number] => 20200345592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => MULTILAYER TYPE POWDER-CONTAINING COSMETIC PREPARATION
[patent_app_type] => utility
[patent_app_number] => 16/642597
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642597 | MULTILAYER TYPE POWDER-CONTAINING COSMETIC PREPARATION | Aug 28, 2018 | Abandoned |
Array
(
[id] => 16420419
[patent_doc_number] => 20200345617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COSMETIC COMPOSITION CONTAINING AQUEOUS GELLING AGENT, AND METHOD FOR PRODUCING AQUEOUS GELLING AGENT AND COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/644031
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644031 | Cosmetic composition containing aqueous gelling agent, and method for producing aqueous gelling agent and cosmetic composition | Aug 27, 2018 | Issued |
Array
(
[id] => 13982259
[patent_doc_number] => 20190060287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => TIZANIDINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/114887
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16114887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/114887 | TIZANIDINE FORMULATIONS | Aug 27, 2018 | Abandoned |
Array
(
[id] => 16710216
[patent_doc_number] => 20210077363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => SPRAYABLE COSMETIC COMPOSITION HAVING A COLOR EFFECT
[patent_app_type] => utility
[patent_app_number] => 16/642752
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642752
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/642752 | SPRAYABLE COSMETIC COMPOSITION HAVING A COLOR EFFECT | Aug 26, 2018 | Abandoned |
Array
(
[id] => 16009137
[patent_doc_number] => 20200179411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES
[patent_app_type] => utility
[patent_app_number] => 16/641564
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641564 | PHARMACEUTICAL SUSPENSIONS FOR BISMUTH SUBSALICYLATES | Aug 23, 2018 | Abandoned |
Array
(
[id] => 16025675
[patent_doc_number] => 10675237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Cosmetic containing foam as carrier
[patent_app_type] => utility
[patent_app_number] => 16/109384
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6883
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109384 | Cosmetic containing foam as carrier | Aug 21, 2018 | Issued |
Array
(
[id] => 16108301
[patent_doc_number] => 20200206173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => A PERSONAL CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/641701
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641701 | A PERSONAL CARE COMPOSITION | Aug 16, 2018 | Abandoned |